UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000023147
Receipt number R000026560
Scientific Title Comparison of bone remodeling between HA coated new implant and conventional implant using 18F-fluoride PET and DEXA
Date of disclosure of the study information 2016/07/13
Last modified on 2020/01/17 11:01:35

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Comparison of bone remodeling between HA coated new implant and conventional implant using 18F-fluoride PET and DEXA

Acronym

PET/DEXA THA study HA vs non HA

Scientific Title

Comparison of bone remodeling between HA coated new implant and conventional implant using 18F-fluoride PET and DEXA

Scientific Title:Acronym

PET/DEXA THA study HA vs non HA

Region

Japan


Condition

Condition

Osteoarthritis of the hip, Osteonecrosis of the femoral head

Classification by specialty

Orthopedics

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Comparison of bone remodeling between Hydroxyapatite coated new implant and conventional implant using 18F-fluoride PET and DEXA

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Confirmatory

Trial characteristics_2

Pragmatic

Developmental phase

Not applicable


Assessment

Primary outcomes

Evaluation of periprosthetic bone mineral density(zero weeks, 24 weeks and 48 weeks after THA) using DEXA.
Evaluation of periprosthetic SUVmax(24 weeeks after THA) using 18F-fluoride PET scan.

Key secondary outcomes

Comparison of clinical scores between Hydroxyapatite coated implant and conventional implant.


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -no one is blinded

Control

Active

Stratification

YES

Dynamic allocation

YES

Institution consideration

Institution is considered as adjustment factor in dynamic allocation.

Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Device,equipment

Interventions/Control_1

Group that has implants with Hydroxyapatite coating on the proximal region of its stem.

Interventions/Control_2

Group that has conventional implants with no Hydroxyapatite coating on the proximal region of its stem.

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

30 years-old <=

Age-upper limit

85 years-old >=

Gender

Male and Female

Key inclusion criteria

Patients whose medical condition is Osteoarthritis of the hip or Osteonecrosis of the femoral head and are in need of primary total hip arthroplasty.

Key exclusion criteria

Patients who did not or could not take the tests required for this study.

Target sample size

50


Research contact person

Name of lead principal investigator

1st name Naomi
Middle name
Last name Kobayashi

Organization

Yokohama City University Medical Center

Division name

Orthopaedics

Zip code

2320024

Address

4-57 Urafune-cho, Minami-ku, Yokohama, Japan

TEL

045-261-5656

Email

naomik58@aol.com


Public contact

Name of contact person

1st name Naomi
Middle name
Last name Kobayashi

Organization

Yokohama City University Medical Center

Division name

Orthopaedics

Zip code

232-0024

Address

4-57 Urafune-cho, Minami-ku, Yokohama, Japan

TEL

045-261-5656

Homepage URL


Email

naomik58@aol.com


Sponsor or person

Institute

Yokohama City University Orthopaedics

Institute

Department

Personal name



Funding Source

Organization

Yokohama City University

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Clinical Research Coordination Department, Center for Novel and Exploratory Clinical Trials

Address

3-9 Fukuura Kanazawa-ku, Yokohama Japan

Tel

045-787-2714

Email

nextjim1@yokohama-cu.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2016 Year 07 Month 13 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

53

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2015 Year 03 Month 18 Day

Date of IRB

2015 Year 04 Month 01 Day

Anticipated trial start date

2015 Year 03 Month 18 Day

Last follow-up date

2020 Year 01 Month 17 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2016 Year 07 Month 13 Day

Last modified on

2020 Year 01 Month 17 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000026560


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name